An Open Label Study of a Peptide Vaccine in Patients With Stage IIb or IIIa Non-Small Cell Lung Cancer

New York Oncology Hematology, Albany

Duke University Medical Center, Durham

Cancer Centers of Florida, Orlando

Mary Crowley Medical Research Center, Dallas

Tyler Cancer Center, Tyler

University of California, Los Angeles, Los Angeles

University of Washington, Seattle

Cancer Care Northwest, Spokane